Patient characteristics
DISEASE PROGRESSION, METASTATIC DISEASE
Of the 8 evaluable patients 50% were below 65 years of age with a range of 50–90 years. All patients had experienced disease progression on prior endocrine therapy and received a median of 1 prior chemotherapy regimen for metastatic disease. Patient characteristics are outlined in Table Patient Demographics and Baseline Characteristics    Male    Female(0/8)(8/8) 100%    Non-Hispanic White    African American    Asian(8/8) 100%(0/8)(0/8)Median (range)Prior endocrine therapy regimens2 (1–3)1 (0–12)